Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-12-23

FDA Approved: EDARAVONE — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved a generic edaravone product from Sandoz Inc under an original application for the treatment of amyotrophic lateral sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Edaravone (Edaravone)

Snippet

ORIG AP for EDARAVONE (EDARAVONE)